Queens University At Kingston

Queen's University At Kingston (doing business as Queen's University) is a Canadian non-profit research institution that serves as a federal grant recipient and contractor, performing medical research, scientific analysis, and advanced research development for U.S. federal agencies as a prime recipient on 71% of recent awards and as a sub-recipient on 29%. The vendor does not compete under any SBA set-aside designation and operates on full-and-open awards across both contract and grant funding streams.

Queen's University's federal footprint centers on biomedical research and specialized scientific analysis. As a prime contractor, the university holds a $1.43 million cost-reimbursable definitive contract with the U.S. Army Corps of Engineers' Humphreys Engineer Center Support Activity for a Strategic Environmental Research and Development Policy (SERDP) project running through January 2030, and a $18 thousand purchase order from the Department of the Interior for polar bear tissue analysis completed in June 2026. As a prime grant recipient, Queen's holds a Defense Health Agency project grant titled "Vitamin C in Thermal Injury: The VICTORY Trial" (ultimate completion September 2027) and an Air Force Research Laboratory project grant on "Populating the Wall Layer, One Eddy at a Time: Resolvent Analysis for Wall-Modelled LES" (ultimate completion January 2026). In its sub-recipient role, the university conducts patient sample collection and genetic analysis under a Washington University sub-award investigating von Willebrand factor biology and disease, delivers intervention development and qualitative research support under a Brigham & Women's Hospital sub-award on HPV vaccine uptake in South Africa, provides neuronal imaging and RNA sequencing work under a Sanford Research sub-award, and participates in multi-institutional consortia focused on cancer screening, blood disease genetics, and critical care nutrition through primes including Memorial Sloan Kettering Cancer Center, The Children's Hospital of Philadelphia, Versiti Blood Health, and others.

The National Institutes of Health and its subdivisions (National Cancer Institute and National Heart, Lung, and Blood Institute) dominate Queen's customer concentration by award count, accounting for 19 of 59 total awards, though the Department of the Army Training and Doctrine Command anchors the top-value ranking with 7 awards carrying $315 thousand in combined potential value. Across all 59 awards, combined potential value totals $1.8 million, but obligated dollars across all awards reach $114.8 million, reflecting large realized project budgets relative to stated ceilings. Only one award completes within the next twenty-four months, indicating minimal near-term recompete exposure. Recent activity averaged two awards per year from 2022 through 2023, accelerated to eight awards in 2024, then moderated to five in 2025 and one in early 2026, with the spike reflecting increased NIH and Army sub-award participation rather than sustained prime-level growth. Awards cluster in biomedical research and development, educational support services, and specialized scientific analysis across NAICS codes spanning research and development in biotechnology, life sciences, and the social sciences.